Diprosalic Scalp Application

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/10/17

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 27/6/2019

Click on this link to Download PDF directly

MSD Ireland (Human Health) Limited

MSD Ireland (Human Health) Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Adempas Film Coated Tablets Active Ingredients Riociguat
Medicine Name Arcoxia 30 60 90 120 film-coated tablets Active Ingredients Etoricoxib
Medicine Name Atozet 10mg/10mg, 10mg/20mg, 10mg/40mg and 10mg/80mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate, ezetimibe
Medicine Name Bridion Active Ingredients Sugammadex sodium
Medicine Name Cancidas 50mg Powder for concentrate for solution for infusion Active Ingredients caspofungin acetate
Medicine Name Cancidas 70mg Powder for concentrate for solution for infusion Active Ingredients caspofungin acetate
Medicine Name Cerazette 75 microgram film-coated tablet Active Ingredients Desogestrel
Medicine Name Cozaar 12.5mg, 50mg & 100mg Film-coated Tablets Active Ingredients Losartan potassium
Medicine Name Cozaar 2.5mg/ml Powder and Solvent for Oral Suspension Active Ingredients Losartan potassium
Medicine Name Cozaar COMP 50 mg/12.5 mg, 100 mg/12.5 mg, 100 mg/25 mg film-coated tablets Active Ingredients Hydrochlorothiazide, Losartan potassium
Medicine Name Cubicin 350mg Powder for Solution for injection or infusion Active Ingredients Daptomycin
Medicine Name Cubicin 500mg powder for solution for injection or infusion Active Ingredients Daptomycin
Medicine Name Delstrigo 100 mg/300 mg/245 mg film-coated tablets Active Ingredients Lamivudine, Tenofovir disoproxil fumarate, Doravirine
Medicine Name Diprosalic Scalp Application Active Ingredients Betamethasone dipropionate, Salicylic Acid
Medicine Name Elocon Cream Active Ingredients Mometasone Furoate
Medicine Name Elocon Ointment Active Ingredients Mometasone Furoate
Medicine Name Elocon Scalp Lotion Active Ingredients Mometasone Furoate
Medicine Name EMEND 125 mg hard capsules Active Ingredients Aprepitant
Medicine Name EMEND 80 mg hard capsules Active Ingredients Aprepitant
Medicine Name EMEND 80mg, 125mg hard Capsules Active Ingredients Aprepitant
Medicine Name Esmeron Active Ingredients Rocuronium Bromide
Medicine Name EZETROL 10 mg Tablets Active Ingredients ezetimibe
Medicine Name FOSAMAX Once Weekly 70 mg Tablets Active Ingredients Alendronate Sodium Trihydrate
Medicine Name FOSAVANCE Active Ingredients Alendronate Sodium Trihydrate, Colecalciferol (Vitamin D3)
Medicine Name GARDASIL Active Ingredients human papillomavirus vaccine
1 - 0 of 84 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 27 June 2019 SmPC

Reasons for updating

  • Improved presentation of SmPC

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Converted the SPC from word document to pdf file format

 

Updated on 25 June 2019 SmPC

Reasons for updating

  • Improved presentation of SmPC

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Converted the SPC from word format to pdf file format 

 

Updated on 10 October 2017 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 10 October 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 10 October 2017 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

SPC change details:  4.4: Visual disturbances and corticosteroid use 4.8: Blurred vision added to list of possible side effects.

Updated on 10 October 2017 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 10 February 2017 PIL

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 19 March 2015 PIL

Reasons for updating

  • Change to side-effects

Updated on 19 March 2015 SmPC

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to Section 4.8 - Undesirable effects

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

  • Change to Section 4.8 - Undesirable effects

Updated on 22 April 2014 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

  • Change to Section 7 - Marketing authorisation holder. IE MAH address changed from Pelham House to Red Oak North  
  • Updated on 22 April 2014 PIL

    Reasons for updating

    • Change to MA holder contact details

    Updated on 29 August 2012 PIL

    Reasons for updating

    • Change to side-effects

    Updated on 7 August 2012 SmPC

    Reasons for updating

    • Change to section 4.4 - Special warnings and precautions for use
    • Change to section 4.6 - Pregnancy and lactation
    • Change to section 4.8 - Undesirable effects
    • Change to section 4.9 - Overdose
    • Change to section 10 - Date of revision of the text

    Legal category: Product subject to medical prescription which may not be renewed (A)

    Free text change information supplied by the pharmaceutical company

    4.4 -  addition of warnings and precautions in line with CDS  
    4.6 - update to text in line with CDS
    4.8 -  addition of side effects in line with CDS
    4.9 -  update to text in line with CDS

    Updated on 5 May 2011 SmPC

    Reasons for updating

    • Change to section 6.3 - Shelf life

    Legal category: Product subject to medical prescription which may not be renewed (A)

    Free text change information supplied by the pharmaceutical company

    Section 6.3 - Reduction in shelf-life from 2 years to 18 months

     

    Updated on 11 April 2011 SmPC

    Reasons for updating

    • Change to section 7 - Marketing authorisation holder
    • Change to section 8 - MA number
    • Change to section 10 - Date of revision of the text

    Legal category: Product subject to medical prescription which may not be renewed (A)

    Free text change information supplied by the pharmaceutical company

    Update of SmPC as a result of legal entity change to MSD.

    Updated on 8 April 2011 PIL

    Reasons for updating

    • Change to date of revision
    • Change to marketing authorisation holder

    Updated on 8 September 2010 PIL

    Reasons for updating

    • Change to storage instructions
    • Change to further information section
    • Change to date of revision
    • Correction of spelling/typing errors

    Updated on 19 January 2010 PIL

    Reasons for updating

    • New PIL for medicines.ie

    Updated on 14 September 2009 SmPC

    Reasons for updating

    • Change to section 1 - Name of medicinal product
    • Change to section 6.2 - Incompatibilities
    • Change to section 6.6 - Special precautions for disposal and other handling
    • Change to section 9 - Date of renewal of authorisation
    • Change to section 10 - Date of revision of the text

    Legal category: Product subject to medical prescription which may not be renewed (A)

    Free text change information supplied by the pharmaceutical company

    Section 1


    From: Diprosalic Ointment

    To: Diprosalic 0.05 % w/w + 3 % w/w Ointment

     

    Section 6.2


    From: None stated

    To: Not applicable

     

    Section 6.6

     

    From: Not applicable

    To: No special requirements

     

    Section 9

     

    Date of renewal updated to 16 March 2007

     

    Section 10

     

    Date of revision of text updated to November 2007

     

    Updated on 28 May 2003 SmPC

    Reasons for updating

    • New SPC for medicines.ie

    Legal category: Product subject to medical prescription which may not be renewed (A)